Lee Che-Hsiung, Cheng Ming-Huei, Wu Chih-Wei, Kuo Wen-Ling, Yu Chi-Chang, Huang Jung-Ju
Ann Plast Surg. 2019 Jan;82(1S Suppl 1):S95-S102. doi: 10.1097/SAP.0000000000001696.
Breast conservation therapy (BCT) is widely accepted for breast cancer treatment. Nipple-sparing mastectomy has been newly developed to preserve the nipple-areolar complex and enhance aesthetic results. The purpose of this study was to evaluate the oncological safety and results of nipple-sparing mastectomy (NSM) after previous BCT.
Eighteen patients who received NSM and immediate breast reconstruction for local recurrence after BCT were identified. An additional 127 affected breasts with NSM and immediate breast reconstruction for primary breast cancer were selected as the control group. The patient disease status, reconstructive method, postoperative complications, and oncological outcome were investigated.
No apparent significant differences between the 2 groups were found regarding patient demographic data, tumor stage, reconstructive method, surgical complication, or tumor recurrence rate (all P values >0.05), except preoperative radiotherapy was higher in secondary NSM group (0% vs 77.8%, P < 0.001). The further nipple and secondary deep inferior epigastric artery perforator flap reconstruction rate was higher in the secondary NSM group (11.1% vs 0.8%, P = 0.041 and 16.7% vs 2.4%, P = 0.026, respectively).
Prior BCT did not contribute to higher surgical complications in patients who received NSM and immediate reconstruction as a salvage procedure after tumor local recurrence. The oncological safety, general surgical result, and postoperative patient-reported satisfaction remain safe and reliable despite prior ipsilateral surgery and radiation. Care should be taken for possible higher nipple necrosis in the secondary NSM patients.
保乳治疗(BCT)已被广泛应用于乳腺癌治疗。乳头保留乳房切除术是一种新开发的术式,旨在保留乳头乳晕复合体并提高美学效果。本研究的目的是评估既往接受BCT后行乳头保留乳房切除术(NSM)的肿瘤学安全性和效果。
确定18例接受NSM及即刻乳房重建以治疗BCT后局部复发的患者。另外选择127例接受NSM及即刻乳房重建治疗原发性乳腺癌的患侧乳房作为对照组。调查患者的疾病状态、重建方法、术后并发症及肿瘤学结局。
两组在患者人口统计学数据、肿瘤分期、重建方法、手术并发症或肿瘤复发率方面均未发现明显差异(所有P值>0.05),但二次NSM组术前放疗率更高(0% 对77.8%,P<0.001)。二次NSM组进一步的乳头及腹壁下深动脉穿支皮瓣重建率更高(分别为11.1% 对0.8%,P = 0.041;16.7% 对2.4%,P = 0.026)。
既往BCT并未导致接受NSM及即刻重建作为肿瘤局部复发后挽救性手术的患者出现更高的手术并发症。尽管既往有同侧手术和放疗史,但肿瘤学安全性、一般手术效果及术后患者报告的满意度仍然安全可靠。对于二次NSM患者,应注意可能出现的更高的乳头坏死发生率。